MYSE MYSE
Company Profile ↓Company Overview
MYSE (MYSE) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $550 (+26.1% YoY); net profit $-2.61M.
- Trailing 12 Months Year-on-year growth — revenue +26.2%.
- 5-Year Trend Long-term compounding — revenue CAGR -40.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -40.69% |
| 1 Year: | 26.15% |
Stock Price Performance
| 1 Year: | +0.86% |
| 6 Months: | +26.49% |
| 3 Months: | +15.84% |
| 1 Month: | +0.43% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross9d ago
- RSI (14)48.28 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -40.7% CAGR over 5 years.
- Trading 38.6% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 809 | 37.95K | 3.54K | 154 | 172 | 175 | 131 | 151 | 62 | 83 | 78 | 328 | 73 |
| Operating Income | - | - | -996.81K | -645.93K | -1.85M | -3.37M | -2.58M | -2.68M | -2.42M | -2.33M | -2.54M | -1.66M | -1.27M | -1.24M | -1.43M | -1.41M | -1.28M | -1.69M |
| Net Income | -205.53K | -329.84K | -996.77K | -645.78K | -1.85M | -3.37M | -2.58M | -2.66M | -2.40M | -2.29M | -2.36M | -1.14M | -983.25K | -1.27M | -1.47M | -1.22M | -1.20M | -2.86M |
| Diluted EPS | - | - | - | -0.05 | -0.12 | -0.71 | -0.13 | -1.29 | -1.16 | -1.10 | -1.13 | -0.41 | -0.33 | -0.42 | -0.36 | -0.29 | -0.28 | -0.67 |
| R&D Expense | - | - | - | - | - | - | - | 258.96K | 282.77K | 337.46K | 380.02K | 233.92K | 226.06K | 363.47K | 6.00K | 5.00K | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | - | 4.45K | 46.21K | 672 | 436 | 550 |
| Operating Income | - | -10.84M | -12.23M | -8.78M | -3.22M | -5.49M |
| Net Income | -979.47K | -10.83M | -12.14M | -8.40M | -4.24M | -2.61M |
| Diluted EPS | - | -0.71 | -6.04 | -4.14 | -1.43 | -0.62 |
| R&D Expense | - | - | 514.96K | 1.35M | 166.67K | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 744.32K | 20.82M | 13.11M | 6.51M | 5.37M | 7.20M |
| Total Equity | -339.88K | 582.33K | 20.08M | 12.56M | 6.10M | 6.88M | 6.10M |
| Cash & Equivalents | - | - | - | 1.73M | 953.36K | 766.99K | 749.03K |
| Total Liabilities | - | 161.99K | 731.00K | 557.11K | 406.55K | 630.31K | 1.09M |
| Current Liabilities | - | 159.99K | 579.99K | 473.44K | 406.55K | 630.31K | 924.79K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.10M | -8.45M | -7.26M | -6.53M | -4.81M | -4.27M |
| Investing Cash Flow | - | -56.04K | -11.21M | 6.16M | 2.24M | -244.24K |
| Financing Cash Flow | 1.72M | 28.02M | 1.11K | -398.28K | 2.39M | 4.49M |
| Capital Expenditure | - | -56.04K | -44.48K | -49.48K | - | -4.47K |
| Free Cash Flow | - | -8.51M | -7.30M | -6.58M | - | -4.27M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | -243,836.9% | -26,456.8% | -1,307,147.5% | -737,882.3% | -998,192.4% |
| Net Margin % | - | -243,622.8% | -26,266.0% | -1,250,739.6% | -972,284.4% | -474,049.5% |
| ROE % | -168.2% | -53.9% | -96.7% | -137.8% | -61.6% | -42.7% |
| ROCE % | - | -53.6% | -96.7% | -144.0% | -67.9% | -87.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MYSE
Why Is Myseum Stock (MYSE) Soaring Today, 04/16/26? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOYUs1Y2Q5N0VBSmMwcWppcVV6YzNadmJHUUd3aTUyZmxnRE04clVFdUw4YUNOOGpQVGJJMEsyYmN3OWJvNDFqTl9PcHpCZFpoUnM1SXlXNFF5Q0VYTU5LRW1oTmxzZDh2bkd6UXJ2dEo3V0d4UXVWYTRfa0JBandoMVNpRkVJZjNuektwZT…
Another absurd AI pivot is propelling a new stock higher Thursday. Shares of Myseum jump 130% - CNBC
<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE1jYUc0X1o3V0YzaXFqRlQ1dTVTNl9YRWNtTjVnNHpoSFNxMkVPdGhQY2xVMnVCMHF1dFo2Y08tUVB6cUI4SDZyUkxZb0pfNGFlOVJfcXNlMXUxaXpEYmdkbEstLVd0REprcUhRTG5Ba1h1ZFV20gF6QVVfeXFMTUEyTnZzLW55SHNGN2plWn…
Why Did MYSE Stock Double Pre-Market Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxObzZHZHdaN3h6STc2SzZ1Q0wzQnJNT3JKd3NZSHEyWF9aOUtZcHpTb0VCd0JUZ2FMdFBhbjVHNF9TNzlwV0RtZXJQa2ZyaXQtQ1lrRGl6eVpDR19RYlRKV19lMHFqYTBLV2NQZlNsTEFCWkR2MEFsVXA1LTlncE5CaWRhWGJSVmwwM2NFQ1…
Myseum (MYSE) spikes on Myseum.AI rebrand and renewed retail momentum | MYSE Stock News - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPbUZQc1hjYkIwcEhjOU9UN21OUTFRT2x2SjdidEhtYkZBSUlQZW5IWHRNU1ZYaXRJbTg4WVFTeTgyTmRIZHVkenluOEZIZkxTM2oyYU1UQlYxRmdPTS1nTEE1R0o1T0V5Q2JKbVdrb2JBT2FHanVnbjFzWWJBcUJoUlRoYU82bHhMbWhLWF…
Myseum adds AI to its name as it builds private social media tools - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQdUNLU1g0VlU3NXhBWjczYTR2dTNMSjJkT09SWl9iSk9INElRalczenFQY1hsdk9ZR2VPQ3hteEIwZDhRU3M3T3A2ZUd5ZzR2aEViWWxoMWFNQVVuU29uM1FtdzhpanItRC02NTRKcmFsWmVVTnhFQTdWNm5udHgydEh6dDJwZ0VKQV81Y1…
Myseum stock soars 100% on rebrand to Myseum.AI - Investing.com
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPOEg3VF9FSEQ0MExpWUpxOEJhWGlpTTJVUXN6ZDVlWlVxZERKUlZvM1JwTVZCb0xzZk42cVlJWXl5cjVQYWVLSGNDMWdrWU0zWm5xWGtEeVZzUTM4VXB0ME40WjBva2J4ZkVTMmNjYks0cGFwc21jNS1mcEVLeWEtYWZqaE9Cd1NYVXowM1…
MYSE — Frequently Asked Questions
What is the current share price of MYSE?
As of 2026-08-05 17:25 PDT, MYSE trades at $2.34 on NASDAQ/NYSE. Its 52-week range is $1.33 to $3.81.
What is the P/E ratio of MYSE?
MYSE trades at a trailing price-to-earnings (P/E) ratio of -3.77.
What is the return on equity (ROE) of MYSE?
MYSE has a return on equity (ROE) of -42.71%. Its return on capital employed (ROCE) is -87.52%.
Is MYSE a good stock to buy?
This page provides a data-driven analysis of MYSE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.